Nuvation Bio NUVB
$3.80 −$0.01 (-0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.80 0.00%
Open$3.77
Prev close$3.81
Day range$3.72 – $3.91
Volume6.85M
Market cap$1.34B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$44.95M+242.6% YoY
Operating profit-$42.21M+25.2% YoY
Net profit-$41.90M+24.9% YoY
Diluted EPS-$0.12+25.0% YoY
Free cash flow-$40.15M+34.1% YoY
Operating cash flow-$38.56M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin85.8%
Operating margin-61.2%
Net margin-67.4%
Return on equity-49.1%
Return on assets-19.7%
Return on invested capital-28.7%
Current ratio7.45
Liabilities / assets70.7%
Cash & investments$663.37M
Total debt$299.66M
Net cash (debt)$363.72M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $44.95M | $31.69M | $83.23M | $62.90M | $41.87M |
| Total Operating Revenue | $44.95M | $31.69M | $83.23M | $62.90M | $41.87M |
| Cost of Revenue | $11.93M | $9.47M | $5.99M | $9.30M | $1.28M |
| Gross Profit | $33.02M | $22.22M | $77.24M | $53.60M | $40.59M |
| Operating Expense | $75.23M | $73.25M | $73.36M | $266.67M | $74.62M |
| Selling and Admin Expenses | $42.55M | $42.59M | $38.31M | $151.56M | $40.33M |
| Research & Development | $32.68M | $30.66M | $35.05M | $115.11M | $34.30M |
| Operating Profit | -$42.21M | -$51.04M | $3.88M | -$213.06M | -$34.04M |
| Net Non-Operating Interest Income (Expense) | $41,000.00 | -$2.16M | -$1.60M | $7.75M | -$1.38M |
| Non-Operating Interest Income | $6.16M | $4.60M | $5.11M | $21.43M | $5.30M |
| Non-Operating Interest Expense | $6.12M | $6.76M | $6.71M | $13.68M | $6.67M |
| Other Income (Expense) | $270,000.00 | -$9.64M | $3.12M | $689,000.00 | -$1.18M |
| Gain on Sale of Security | -$13,000.00 | $9,000.00 | $2.87M | -$807,000.00 | -$1.12M |
| Special Income (Charges) | $0.00 | -$9.47M | – | -$33,000.00 | -$3,000.00 |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | $1,000.00 | – | -$33,000.00 | -$3,000.00 |
| Other Non-Operating Income (Expenses) | $283,000.00 | -$179,000.00 | $243,000.00 | $1.53M | -$51,000.00 |
| Pretax Profit | -$41.90M | -$62.84M | $5.40M | -$204.63M | -$36.59M |
| Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Profit | -$41.90M | -$62.84M | $5.40M | -$204.63M | -$36.59M |
| Profit from Continuing Operations | -$41.90M | -$62.84M | $5.40M | -$204.63M | -$36.59M |
| Net Income to Parent Company | -$41.90M | -$62.84M | $5.40M | -$204.63M | -$36.59M |
| Net Income to Common Stockholders | -$41.90M | -$62.84M | $5.40M | -$204.63M | -$36.59M |
| Basic EPS | -$0.12 | -$0.18 | $0.02 | -$0.60 | -$0.11 |
| Diluted EPS | -$0.12 | -$0.18 | $0.01 | -$0.60 | -$0.11 |
| -Less:Other Special Charges | – | $9.47M | – | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $778.39M | $744.50M | $610.24M | $594.82M | $594.82M |
| Total Current Assets | $734.66M | $726.43M | $591.53M | $571.52M | $571.52M |
| Cash and Cash Equivalents & Short-Term Investments | $663.37M | $660.96M | $533.73M | $529.21M | $529.21M |
| -Cash and Cash Equivalents | $153.77M | $258.60M | $125.39M | $164.09M | $164.09M |
| -Short Term Investments | $509.60M | $402.35M | $408.34M | $365.13M | $365.13M |
| Receivables | $40.22M | $31.71M | $25.98M | $19.36M | $19.36M |
| -Accounts Receivable | $36.55M | $27.83M | $22.72M | $16.08M | $16.08M |
| -Accrued Interest Receivable | $3.68M | $3.89M | $3.26M | $3.29M | $3.29M |
| Inventory | $15.34M | $19.90M | $15.84M | $11.41M | $11.41M |
| Other Current Assets | $15.73M | $13.86M | $15.97M | $11.54M | $11.54M |
| Total Non-Current Assets | $43.73M | $18.07M | $18.71M | $23.30M | $23.30M |
| Net PPE | $16.41M | $3.96M | $4.13M | $4.48M | $4.48M |
| -Gross PPE | $17.82M | $5.29M | $5.39M | $5.67M | $5.67M |
| -Accumulated Depreciation | -$1.42M | -$1.33M | -$1.26M | -$1.18M | -$1.18M |
| Goodwill and Other Intangible Assets | $19.80M | $10.29M | $10.76M | $11.21M | $11.21M |
| Other Non-Current Assets | $7.52M | $3.82M | $3.82M | $7.61M | $7.61M |
| Total Liabilities | $550.42M | $490.64M | $290.68M | $289.11M | $289.11M |
| Total Current Liabilities | $98.56M | $86.76M | $79.52M | $82.23M | $82.23M |
| Payables | $9.45M | $12.09M | $22.44M | $9.77M | $9.77M |
| -Accounts Payable | $9.45M | $12.09M | $22.44M | $9.48M | $9.48M |
| Current Accrued Expenses | $57.14M | $45.20M | $32.86M | $24.90M | $24.90M |
| Short-Term Debt and Capital Lease Obligation | $6.40M | $7.61M | $7.63M | $7.60M | $7.60M |
| -Current Debt | $5.97M | $5.89M | $5.79M | $5.72M | $5.72M |
| -Current Capital Lease Obligation | $436,000.00 | $1.72M | $1.84M | $1.88M | $1.88M |
| Current Deferred Liabilities | $9.06M | $8.86M | $8.65M | $7.52M | $7.52M |
| Other Current Liabilities | $16.51M | $13.00M | $7.94M | $12.45M | $12.45M |
| Total Non-Current Liabilities | $451.86M | $403.88M | $211.16M | $206.88M | $206.88M |
| Long Term Debt and Capital Lease Obligation | $293.69M | $244.53M | $49.53M | $49.75M | $49.75M |
| -Long Term Debt | $279.46M | $242.62M | $47.33M | $47.21M | $47.21M |
| -Long Term Capital Lease Obligation | $14.23M | $1.91M | $2.20M | $2.54M | $2.54M |
| Non-Current Deferred Liabilities | $6.65M | $8.23M | $9.74M | $11.31M | $11.31M |
| Other Non-Current Liabilities | $151.52M | $151.12M | $151.89M | $145.82M | $145.82M |
| Total Equity | $227.98M | $253.86M | $319.56M | $305.72M | $305.72M |
| Stockholders' Equity | $227.98M | $253.86M | $319.56M | $305.72M | $305.72M |
| Capital Stock | $1.45B | $1.43B | $1.43B | $1.42B | $1.42B |
| -Common Stock | $1.45B | $1.43B | $1.43B | $1.42B | $1.42B |
| Retained Earnings | -$1.21B | -$1.17B | -$1.11B | -$1.12B | -$1.12B |
| Gains/Losses Not Affecting Retained Earnings | -$4.62M | -$2.61M | -$1.68M | -$187,000.00 | -$187,000.00 |
| -Total Tax Payable | – | – | – | $286,000.00 | $286,000.00 |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$38.56M | -$42.97M | $5.07M | -$173.43M | -$29.73M |
| Net cash flow from continuing operations | -$38.56M | -$42.97M | $5.07M | -$173.43M | -$29.73M |
| Net Income from Continuing Operations | -$41.90M | -$62.84M | $5.40M | -$204.63M | -$36.59M |
| Gain/Loss from Continuing Operations | -$242,000.00 | $9.25M | -$2.89M | -$245,000.00 | $457,000.00 |
| Depreciation & Depletion & Amortization | $578,000.00 | $536,000.00 | $536,000.00 | $1.74M | $539,000.00 |
| Other Non-Cash Items | $5.62M | $5.39M | $5.33M | $11.08M | $5.34M |
| Change in Working Capital | -$11.53M | -$5.06M | -$11.50M | -$11.98M | -$6.28M |
| -Change in Receivables | -$8.51M | -$5.73M | -$6.62M | -$3.07M | -$5.51M |
| -Change in Inventory | $4.56M | -$4.06M | -$4.43M | -$11.41M | -$5.70M |
| -Change in Prepaid Assets | -$1.87M | $2.11M | -$4.44M | -$4.27M | -$2.61M |
| -Change in Payables and Accrued Expense | -$637,000.00 | $3.93M | $637,000.00 | $15.48M | $6.72M |
| -Change in Other Current Assets | -$3.70M | $0.00 | $3.78M | -$846,000.00 | -$145,000.00 |
| -Change In Other Working Capital | -$1.37M | -$1.31M | -$426,000.00 | -$7.87M | $969,000.00 |
| Net cash flow from investing | -$109.34M | $5.99M | -$43.64M | $99.52M | $87.08M |
| Net Cash Flow from Continuing Investing Activities | -$109.34M | $5.99M | -$43.64M | $99.52M | $87.08M |
| Net PPE Purchase and Sale | -$1.59M | -$254,000.00 | -$48,000.00 | -$354,000.00 | -$89,000.00 |
| Net Investment Purchase and Sale | -$107.76M | $6.25M | -$43.59M | $107.87M | $87.17M |
| Financing Cash Flow | $43.17M | $170.53M | $44,000.00 | $202.54M | $8.06M |
| Net Cash Flow from Continuing Financing Activities | $43.17M | $170.53M | $44,000.00 | $202.54M | $8.06M |
| Net Issuance Payments Of Debt | $36.57M | $185.06M | $0.00 | $48.20M | $2,000.00 |
| Net Common Stock Issuance | $0.00 | – | – | – | – |
| Proceeds from Stock Option Exercised | $7.95M | $4.75M | $908,000.00 | $11.42M | $8.49M |
| Net Other Financing Charges | -$1.35M | -$2.15M | -$864,000.00 | $142.91M | -$425,000.00 |
| Ending Cash Balance | $153.77M | $258.60M | $125.39M | $164.09M | $164.09M |
| Net Change in Cash | -$104.74M | $133.55M | -$38.52M | $128.63M | $65.41M |
| Beginning Cash Balance | $258.60M | $125.39M | $164.09M | $35.72M | $98.90M |
| Effect of Exchange Rate Changes | -$98,000.00 | -$338,000.00 | -$172,000.00 | -$265,000.00 | -$224,000.00 |
| Free Cash Flow | -$40.15M | -$43.22M | $5.02M | -$181.78M | -$29.82M |
| Net Intangibles Purchase and Sale | – | – | – | -$8.00M | $0.00 |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on NUVB.
Sign in to join the discussion.